- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/20 - Spiro-condensed systems
Patent holdings for IPC class C07D 487/20
Total number of patents in this class: 220
10-year publication summary
|
14
|
14
|
14
|
13
|
20
|
16
|
16
|
18
|
17
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pharmacosmos Holding A/S | 198 |
20 |
| Pharmacosmos A/S | 66 |
19 |
| Boehringer Ingelheim International GmbH | 4698 |
11 |
| G1 Therapeutics, Inc. | 57 |
7 |
| BeiGene Switzerland GmbH | 247 |
7 |
| Daiichi Sankyo Company, Limited | 1855 |
5 |
| Enanta Pharmaceuticals, Inc. | 428 |
5 |
| Novartis AG | 10883 |
4 |
| Merck Patent GmbH | 5850 |
4 |
| Bayer AG | 3308 |
4 |
| Deutsches Krebsforschungszentrum | 418 |
4 |
| Relay Therapeutics, Inc. | 68 |
4 |
| Bristol-myers Squibb Company | 4875 |
3 |
| Amgen Inc. | 4055 |
3 |
| Temple University of the Commonwealth System of Higher Education | 607 |
3 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3131 |
3 |
| Lunella Biotech, Inc. | 103 |
3 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 175 |
3 |
| Ascentage Pharma Group Corp Limited | 124 |
3 |
| Shanghai Simr Biotechnology Co., Ltd | 22 |
3 |
| Other owners | 102 |